We are live on
!
Find out more
Madrigal Pharmaceuticals
MDGL
MDGL
100 hedge funds and large institutions have $739M invested in Madrigal Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 38 increasing their positions, 24 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
58% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 24
57% more capital invested
Capital invested by funds: $471M → $739M (+$268M)
53% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 19
10% more funds holding
Funds holding: 91 → 100 (+9)
7.95% more ownership
Funds ownership: 36.5% → 44.46% (+8%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
100
Holders Change
+9
Holders Change %
+9.89%
% of All Funds
2.29%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
29
Increased
38
Reduced
24
Closed
19
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
+$123M |
| 2 |
State Street
Boston,
Massachusetts
|
+$48.2M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
+$31.6M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$23M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$15.1M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$61.3M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$24.9M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$23.5M |
| 4 |
AC
Ascend Capital
Orinda,
California
|
-$10.8M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$9.89M |
